GlassScriptPhysician profile
Jonathan G Ownby
NPI 1780887877
$291,281.84
in general payments reported to CMS, 2019-2025
73 companies · $58K in 2025
The $58K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $15K · 2021: $33K · 2022: $18K · 2023: $29K · 2024: $88K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90K · Consulting Fee: $27K · Honoraria: $20K · Food and Beverage: $16K · Travel and Lodging: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,580 · Education: $64.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,365.00 |
| Consulting Fee | $27,240.00 |
| Honoraria | $20,253.00 |
| Food and Beverage | $16,127.73 |
| Travel and Lodging | $12,316.77 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,580.00 |
| Education | $64.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $230,774.20 | 2019-2025 | Korlym |
| Merck Sharp & Dohme LLC | $14,193.39 | 2019-2023 | Steglatro, Januvia, Steglujan |
| Abbvie INC. | $12,068.05 | 2019-2024 | |
| Lilly USA, LLC | $6,497.26 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $6,199.24 | 2019-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $2,677.32 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $2,059.53 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $1,473.68 | 2019-2025 | |
| Amgen INC. | $1,437.94 | 2019-2025 | Tepezza, Repatha, Evenity |
| Xeris Pharmaceuticals, INC. | $1,414.90 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $931.84 | 2019-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $921.02 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Tandem Diabetes Care, INC. | $762.78 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Novartis Pharmaceuticals Corporation | $717.80 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $705.70 | 2019-2025 | Unithroid |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $653.38 | 2019-2024 | Farxiga |
| Beta Bionics, INC. | $603.05 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Dexcom, INC. | $587.10 | 2019-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $496.17 | 2021-2025 | Cequr Simplicity |
| Chiesi USA, INC. | $447.56 | 2024-2025 | Mycapssa, Myalept, Juxtapid |
| Amarin Pharma, INC. | $438.17 | 2019-2022 | |
| Senseonics, Incorporated | $400.00 | 2019 | |
| Radius Health, INC. | $369.51 | 2021-2025 | Tymlos |
| Ibsa Pharma INC. | $316.24 | 2019-2025 | Licart, Tirosint, Tirosint |
| Bigfoot Biomedical INC | $315.39 | 2022-2023 | Unity Diabetes Management System |
| Zealand Pharma US, INC. | $302.33 | 2020-2022 | |
| Madrigal Pharmaceuticals | $245.27 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.98 | 2019-2023 | Cycloset |
| Janssen Pharmaceuticals, INC | $185.81 | 2019-2020 | |
| Grt US Holding, INC. | $178.63 | 2021-2022 | |
| Becton, Dickinson and Company | $169.29 | 2019-2021 | |
| Medtronic Minimed, INC. | $149.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.04 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $140.24 | 2020-2023 | Xiaflex, Aveed |
| Valeritas, INC. | $138.89 | 2019 | |
| Averitas Pharma INC. | $133.97 | 2023-2025 | Qutenza |
| Medtronic, INC. | $131.56 | 2019-2023 | Minimed 780g |
| Kvk-Tech, INC. | $124.31 | 2019 | |
| Esperion Therapeutics, INC. | $121.10 | 2020-2024 | Nexletol |
| Alexion Pharmaceuticals, INC. | $110.05 | 2019-2024 | Strensiq |
| Lifescan, INC. | $102.41 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $100.62 | 2019-2021 | |
| Embecta Corp. | $80.00 | 2024 | Bd Nano 2nd Gen Pen Needle |
| Eisai INC. | $79.51 | 2019-2023 | |
| Currax Pharmaceuticals LLC | $75.50 | 2020-2023 | Contrave |
| Horizon Therapeutics Plc | $75.38 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $62.25 | 2021-2025 | Isturisa, Signifor Lar |
| Astellas Pharma US INC | $59.00 | 2024-2025 | Veozah |
| Neurocrine Biosciences, INC. | $56.08 | 2025 | |
| Ascendis Pharma Endocrinology INC | $47.75 | 2025 | Yorvipath, Skytrofa |
| Amphastar Pharmaceuticals, INC. | $45.25 | 2024-2025 | |
| Shire North American Group INC | $42.99 | 2019 | |
| Ascensia Diabetes Care US INC. | $41.56 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $41.21 | 2021-2022 | |
| Kyowa Kirin, INC. | $36.72 | 2025 | |
| Clarus Therapeutics INC. | $35.34 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $34.27 | 2019 | |
| Companion Medical, INC. | $33.32 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $33.10 | 2025 | Imcivree |
| Takeda Pharmaceuticals U.S.A., INC. | $32.68 | 2021-2024 | Trintellix |
| Acerus Pharmaceuticals Corporation | $30.39 | 2022 | |
| Amryt Pharma Holdings LTD | $29.22 | 2021-2022 | |
| Sequel Med Tech, LLC | $20.77 | 2025 | Twiist |
| Verity Pharmaceuticals INC. | $20.68 | 2024 | Tlando |
| Nestle Healthcare Nutrition INC. | $20.35 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.95 | 2020 | |
| Intuity Medical INC | $17.95 | 2022 | |
| Tolmar, INC. | $17.19 | 2025 | Jatenzo |
| Antares Pharma, INC. | $17.08 | 2020 | |
| Vivus LLC | $14.87 | 2021 | |
| Nevro Corp. | $14.16 | 2021 | |
| Aytu Biopharma, INC. | $11.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,056.17 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ownby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.